NetworkNewsBreaks

MondayNov 02, 2020 3:11 pm

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Advancing CBD Research to Bring Innovative Products to Underserved Markets

Jupiter Wellness (NASDAQ: JUPW) is a functional wellness and natural health products company. It leverages a proprietary line of offerings formulated to provide the therapeutic and medical benefits of cannabidiol (“CBD”). Jupiter Wellness is dedicated to advancing research into CBD for treatment and relief of a range of ailments, including ultraviolet exposure, psoriasis, eczema, skin aging and other conditions. Formed in 2018 and headquartered in Jupiter, Florida, Jupiter’s award-winning portfolio contains seven unique CBD brands targeting specific niches of the larger CBD space. Jupiter Wellness retails its full portfolio of brands and products on its ecommerce site at www.CBDCaring.com. For…

Continue Reading

MondayNov 02, 2020 2:44 pm

NetworkNewsBreaks – Cybin Corp. Paves Path to Profitability with Health-Care Veteran at the Helm

Cybin Corp., a Canada-based, life-science company advancing psychedelic pharmaceuticals, recently announced the appointment of Doug Drysdale as its CEO (https://nnw.fm/wPyaa). Drysdale, named an Ernst and Young Entrepreneur of the Year in 2012, brings more than three decades of experience in the health-care sector and will continue to grow the company’s IP portfolio. “With his myriad of business accomplishments, Doug is the ideal leader for Cybin,” stated Cybin co-founder and COO Paul Glavine of the appointment. “We believe that his extensive health-care sector background and international company management skills will help Cybin strengthen partnerships, develop strategic alliances and expand our international…

Continue Reading

MondayNov 02, 2020 2:11 pm

NetworkNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Prioritizes Quality Through ‘The Future of Genetics’ Approach

Pac Roots (CSE: PACR), an innovative genetics-based cannabis company located in Canada, places a top priority on producing premium-quality cannabis strains and products. In fact, while competitors may strive to be the largest cannabis grower, Pac Roots, with its slogan proclaiming “the Future of Genetics,” maintains that the quality of the product is paramount. A recent article discussing this reads, “Pac Roots achieves its goal of producing the highest-quality cannabis by relying on superior genetics, following optimized farming systems and growing in carefully selected cultivation sites. The company’s commitment to superior genetics is represented by its strategic licensing agreement with…

Continue Reading

MondayNov 02, 2020 1:50 pm

NetworkNewsBreaks – Why Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Is ‘One to Watch’

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options. A recent article discussing the company reads, “Headquartered in Hanover, Maryland, Processa has built a pipeline of drugs, which already have proof-of-concept data supporting clinical use in their selected indications. The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete. More specifically, Processa: acquires drugs that already have some clinical data to support the targeted treatment; navigates through…

Continue Reading

MondayNov 02, 2020 1:26 pm

NetworkNewsBreaks – Sanwire Corp. (SNWR) Empowers Artists to Innovate, Create During Pandemic

Sanwire (OTC: SNWR), dedicated to employing digital technologies to provide a wide range of solutions for independent artists, stands to benefit from growing demand in the music industry. According to a report by MIDiA Research, digital technology and social media tools provide independent artists with powerful capabilities to create content and engage with fans during COVID-19 (https://nnw.fm/Fwled). “This is where Sanwire steps in to fill this growing market need as a company offering digital solutions to empower independent artists with a marketing system specifically built for them,” a recent article reads. “Through its subsidiary Intercept Music, Sanwire provides music artists…

Continue Reading

MondayNov 02, 2020 12:29 pm

NetworkNewsBreaks – Organic Flower Investments Group Inc. (CSE: SOW) (OTC: QILFF) (FWB: 2K6) Announces Grant of Stock Options

Organic Flower (CSE: SOW) (OTC: QILFF) (FWB: 2K6) recently announced that, pursuant to the company’s stock option plan, it has granted incentive stock options to its directors, officers, employees and consultants. The options will allow the purchase of an aggregate of 5,000,000 common shares, with an exercise price of 0.19 per share, for up to five years. To view the full press release, visit https://nnw.fm/gHNkt About Organic Flower Investments Group Inc. Organic Flower specializes in investing into private and public companies engaged in a variety of industries, with a focus in the bio-medical, pharmaceutical and naturopathic sectors, which may include…

Continue Reading

MondayNov 02, 2020 12:10 pm

NetworkNewsBreaks – Oncocyte Corporation (NYSE American: OCX) Announces Q3 Growth of DetermaRx(TM) Physician Adoption, Testing Volume

Oncocyte (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, recently provided an update on DetermaRx’s global growth and adoption. According to the update, DetermaRx is a treatment stratification test that identifies stage I-IIA non-small cell lung cancer (“NSCLC”) patients at high risk of recurrence, despite ostensibly curative surgery, who may benefit from the addition of chemotherapy. Since its January commercial launch in the U.S., DetermaRx has begun to be reimbursed by Medicare and multiple private payers and has seen rapid adoption across 67 hospitals. “We…

Continue Reading

MondayNov 02, 2020 11:49 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Secures $6.9M in Private Placement

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, earlier this year announced the closing of a private placement financing (the “offering”). According to the update, AzurRx secured approximately $6.9 million in gross proceeds from certain accredited investors, with Alexander Capital LP acting as sole placement agent in the offering. The company intends to use net proceeds to eliminate short- and long-term indebtedness, as well as for general working capital purposes including product development. “We are very grateful for the continued support of our investors,” James Sapirstein, president and CEO of AzurRx said…

Continue Reading

MondayNov 02, 2020 11:30 am

NetworkNewsBreaks – Knightscope Inc. Secures Purchase Order from California Water District

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, recently announced its receipt of a purchase order from a California Water District to help protect the supply of clean/safe water to consumers. The company’s advanced physical security technologies hold significant potential in securing indoor or outdoor operations where a security guard or officer is needed. Knightscope further requested that potential clients and decision makers request a demonstration for the company to showcase how its Autonomous Security Robots (“ASRs”) may help with security needs across the U.S. For more details, visit https://nnw.fm/jHrVu…

Continue Reading

MondayNov 02, 2020 11:03 am

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Announces Granting of Stock Options, Appointment of New CEO

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that, per its stock option plan, it has granted an aggregate of 1,850,000 incentive stock options to directors, officers and advisors of the company. According to the update, the stock options will vest immediately and be exercisable to purchase one common share in the capital of the company on or before November 2, 2025, at a price of $0.42 per share. In addition, GoldHaven announced the appointment of Daniel Schieber as its chief executive officer and a director…

Continue Reading